Paraoxonase I Activity and Its Relationship with Nutrition in Amyotrophic Lateral Sclerosis
- PMID: 39199265
- PMCID: PMC11351986
- DOI: 10.3390/antiox13081021
Paraoxonase I Activity and Its Relationship with Nutrition in Amyotrophic Lateral Sclerosis
Abstract
Background: Amyotrophic lateral sclerosis (ALS) is characterized by progressive motor neuron degeneration, with oxidative stress playing a key role. Paraoxonase 1 (PON1) is an antioxidant enzyme that may influence ALS progression. This study aimed to establish a predictive model for the influence of PON1 activity on functionality in ALS patients and explore its relationship with nutrition. Methods: In this observational cross-sectional study, 70 ALS patients underwent assessments of PON1 activity, lipid profile, functional capacity, respiratory function, and heart rate variability. A structural equation model was developed to determine the relationships between variables. Nutritional intake was analyzed in 65 patients. Results: The predictive model showed that PON1 activity and LDL levels positively influenced functionality, both directly and indirectly through respiratory capacity. Heart rate variability moderately predicted functionality independently. HDL levels were not significantly associated with functionality. Weak to moderate correlations were found between PON1 activity and intake of certain nutrients, with positive associations for monounsaturated fats and vitamin D, and negative associations for carbohydrates, proteins, and some micronutrients. Conclusions: PON1 activity appears to play an important role in ALS patient functionality, both directly and through effects on respiratory capacity. However, its relationship with nutritional intake was not strongly evident in this sample population.
Keywords: ALS; high density lipoprotein; nutrition; paraoxonase-1; pulmonary function.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Paraoxonase 1 (PON1) organophosphate hydrolysis is not reduced in ALS.Neurology. 2008 Mar 18;70(12):929-34. doi: 10.1212/01.wnl.0000305956.37931.dd. Neurology. 2008. PMID: 18347314
-
Association of serum amyloid A and oxidative stress with paraoxonase 1 in sarcoidosis patients.Eur J Clin Invest. 2016 May;46(5):418-24. doi: 10.1111/eci.12610. Epub 2016 Mar 17. Eur J Clin Invest. 2016. PMID: 26919159
-
Association between serum paraoxonase 1 activity and its polymorphisms with multiple sclerosis: a systematic review.Neurol Sci. 2021 Feb;42(2):491-500. doi: 10.1007/s10072-020-04842-3. Epub 2020 Oct 23. Neurol Sci. 2021. PMID: 33095366
-
Paraoxonase 1 Q192R and L55M polymorphisms and susceptibility to amyotrophic lateral sclerosis: a meta-analysis.Neurol Sci. 2015 Jan;36(1):11-20. doi: 10.1007/s10072-014-1979-y. Epub 2014 Oct 10. Neurol Sci. 2015. PMID: 25301263 Review.
-
Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis.Free Radic Biol Med. 2013 Dec;65:509-527. doi: 10.1016/j.freeradbiomed.2013.06.029. Epub 2013 Jun 21. Free Radic Biol Med. 2013. PMID: 23797033 Free PMC article. Review.
References
-
- Rojas P., Ramírez A.I., Fernández-Albarral J.A., López-Cuenca I., Salobrar-García E., Cadena M., Elvira-Hurtado L., Salazar J.J., de Hoz R., Ramírez J.M. Amyotrophic Lateral Sclerosis: A Neurodegenerative Motor Neuron Disease with Ocular Involvement. Front. Neurosci. 2020;14:566858. doi: 10.3389/fnins.2020.566858. - DOI - PMC - PubMed
-
- Zhang Q.J., Huang J.C., Chen J., Hu W., Xu L.Q., Guo Q.F. Peak expiratory flow is a reliably household pulmonary function parameter correlates with disease severity and survival of patients with amyotrophic lateral sclerosis. BMC Neurol. 2022;22:105. doi: 10.1186/s12883-022-02635-z. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous